{ "company_number": "07214213", "name": "Kiani & Wasag Pharmaceutics Ltd", "url": "/company/07214213", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2010-04-07", "dissolved_on": null, "sic_codes": [ { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 1014673, "url": "/address/1014673", "line1": "167-169 GREAT PORTLAND STREET", "line2": "FIFTH FLOOR", "post_town": "LONDON", "county": "", "country": "", "postcode": "W1W 5PF" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07214213", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-01-31", "last_made_up": "2025-04-30", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/07214213/accounts/2025-04-30", "pdf_url": "/company/07214213/accounts/2025-04-30.pdf", "made_up_date": "2025-04-30", "period_start": "2025-04-30", "period_end": "2025-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "71926.00", "current_assets": "71926.00", "creditors_due_within_one_year": "4991.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "66935.00", "total_assets_less_current_liabilities": "66935.00", "net_assets_liabilities": "66935.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "66835.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2026.zip" }, { "url": "/company/07214213/accounts/2024-04-30", "pdf_url": "/company/07214213/accounts/2024-04-30.pdf", "made_up_date": "2024-04-30", "period_start": "2024-04-30", "period_end": "2024-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "2821.00", "debtors": "23575.00", "cash_bank_in_hand": "56377.00", "current_assets": "79952.00", "creditors_due_within_one_year": "4787.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "75165.00", "total_assets_less_current_liabilities": "77986.00", "net_assets_liabilities": "77986.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "77886.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2025.zip" }, { "url": "/company/07214213/accounts/2023-04-30", "pdf_url": "/company/07214213/accounts/2023-04-30.pdf", "made_up_date": "2023-04-30", "period_start": "2023-04-30", "period_end": "2023-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "3440.00", "debtors": "34875.00", "cash_bank_in_hand": "51945.00", "current_assets": "86820.00", "creditors_due_within_one_year": "7682.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "79138.00", "total_assets_less_current_liabilities": "82578.00", "net_assets_liabilities": "82578.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "82478.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2024.zip" }, { "url": "/company/07214213/accounts/2022-04-30", "pdf_url": "/company/07214213/accounts/2022-04-30.pdf", "made_up_date": "2022-04-30", "period_start": "2022-04-30", "period_end": "2022-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "4195.00", "debtors": "35719.00", "cash_bank_in_hand": "38870.00", "current_assets": "74589.00", "creditors_due_within_one_year": "6954.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "67635.00", "total_assets_less_current_liabilities": "71830.00", "net_assets_liabilities": "71830.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "71730.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2023.zip" }, { "url": "/company/07214213/accounts/2021-04-30", "pdf_url": "/company/07214213/accounts/2021-04-30.pdf", "made_up_date": "2021-04-30", "period_start": "2021-04-30", "period_end": "2021-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "5117.00", "debtors": "31015.00", "cash_bank_in_hand": "13500.00", "current_assets": "44515.00", "creditors_due_within_one_year": "3453.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "41062.00", "total_assets_less_current_liabilities": "46179.00", "net_assets_liabilities": "46179.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "46079.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2022.zip" }, { "url": "/company/07214213/accounts/2020-04-30", "pdf_url": "/company/07214213/accounts/2020-04-30.pdf", "made_up_date": "2020-04-30", "period_start": "2020-04-30", "period_end": "2020-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "6240.00", "debtors": "26404.00", "cash_bank_in_hand": "3055.00", "current_assets": "29459.00", "creditors_due_within_one_year": "2238.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "27221.00", "total_assets_less_current_liabilities": "33461.00", "net_assets_liabilities": "33461.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "33361.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2021.zip" }, { "url": "/company/07214213/accounts/2019-04-30", "pdf_url": "/company/07214213/accounts/2019-04-30.pdf", "made_up_date": "2019-04-30", "period_start": "2019-04-30", "period_end": "2019-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "7610.00", "debtors": "20050.00", "cash_bank_in_hand": null, "current_assets": "20050.00", "creditors_due_within_one_year": "1741.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "18309.00", "total_assets_less_current_liabilities": "25919.00", "net_assets_liabilities": "25919.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "25819.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2020.zip" }, { "url": "/company/07214213/accounts/2018-04-30", "pdf_url": "/company/07214213/accounts/2018-04-30.pdf", "made_up_date": "2018-04-30", "period_start": "2018-04-30", "period_end": "2018-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "9281.00", "debtors": null, "cash_bank_in_hand": "13448.00", "current_assets": "13448.00", "creditors_due_within_one_year": "2235.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "11213.00", "total_assets_less_current_liabilities": "20494.00", "net_assets_liabilities": "20494.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "20394.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2019.zip" }, { "url": "/company/07214213/accounts/2017-04-30", "pdf_url": "/company/07214213/accounts/2017-04-30.pdf", "made_up_date": "2017-04-30", "period_start": "2017-04-30", "period_end": "2017-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "11318.00", "debtors": null, "cash_bank_in_hand": "6740.00", "current_assets": "6740.00", "creditors_due_within_one_year": "2095.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4645.00", "total_assets_less_current_liabilities": "15963.00", "net_assets_liabilities": "15963.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "15863.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2018.zip" }, { "url": "/company/07214213/accounts/2016-04-30", "pdf_url": "/company/07214213/accounts/2016-04-30.pdf", "made_up_date": "2016-04-30", "period_start": "2016-04-30", "period_end": "2016-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "13802.00", "debtors": null, "cash_bank_in_hand": "1437.00", "current_assets": "1437.00", "creditors_due_within_one_year": "2699.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-1262.00", "total_assets_less_current_liabilities": "12540.00", "net_assets_liabilities": "12540.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "12440.00", "shareholder_funds": "12540.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2017.zip" }, { "url": "/company/07214213/accounts/2015-04-30", "pdf_url": "/company/07214213/accounts/2015-04-30.pdf", "made_up_date": "2015-04-30", "period_start": "2015-04-30", "period_end": "2015-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "16832.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": "3421.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-3421.00", "total_assets_less_current_liabilities": "13411.00", "net_assets_liabilities": "13411.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "13311.00", "shareholder_funds": "13411.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2016.zip" }, { "url": "/company/07214213/accounts/2014-04-30", "pdf_url": "/company/07214213/accounts/2014-04-30.pdf", "made_up_date": "2014-04-30", "period_start": "2014-04-30", "period_end": "2014-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "2190.00", "current_assets": "2190.00", "creditors_due_within_one_year": "2090.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "100.00", "total_assets_less_current_liabilities": "100.00", "net_assets_liabilities": "100.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "0.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2015.zip" }, { "url": "/company/07214213/accounts/2013-04-30", "pdf_url": "/company/07214213/accounts/2013-04-30.pdf", "made_up_date": "2013-04-30", "period_start": "2013-04-30", "period_end": "2013-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "12437.00", "current_assets": "12437.00", "creditors_due_within_one_year": "2584.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "9853.00", "total_assets_less_current_liabilities": "9853.00", "net_assets_liabilities": "9853.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "9753.00", "shareholder_funds": "9853.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2014.zip" }, { "url": "/company/07214213/accounts/2012-04-30", "pdf_url": "/company/07214213/accounts/2012-04-30.pdf", "made_up_date": "2012-04-30", "period_start": "2012-04-30", "period_end": "2012-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "943.00", "cash_bank_in_hand": "32917.00", "current_assets": "33860.00", "creditors_due_within_one_year": "3543.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "30317.00", "total_assets_less_current_liabilities": "30317.00", "net_assets_liabilities": "30317.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "30217.00", "shareholder_funds": "30317.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2012.zip" }, { "url": "/company/07214213/accounts/2011-04-30", "pdf_url": "/company/07214213/accounts/2011-04-30.pdf", "made_up_date": "2011-04-30", "period_start": "2011-04-30", "period_end": "2011-04-30", "entity_name": "Kiani & Wasag Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "21794.00", "current_assets": "21794.00", "creditors_due_within_one_year": "4273.00", "creditors_due_after_one_year": "1345.00", "net_current_assets_liabilities": "17521.00", "total_assets_less_current_liabilities": "17521.00", "net_assets_liabilities": "16176.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "16076.00", "shareholder_funds": "16176.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2011.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07214213/filing-history" }, "confirmation_statement": { "next_due": "2027-04-21", "last_made_up": "2026-04-07" }, "officers": [], "psc": [ { "name": "Mr Amir Raza Kiani", "kind": "individual-person-with-significant-control", "person_url": "/person/290808", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2017-04-07", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:43:52.697050+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }